- Home
- IMCR vs EVEX Comparison
IMCR vs EVEX Comparison
Compare IMCR & EVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- EVEX
- Stock Information
- Founded
- IMCR 2008
- EVEX 2020
- Country
- IMCR United Kingdom
- EVEX United States
- Employees
- IMCR N/A
- EVEX N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- EVEX Aerospace
- Sector
- IMCR Health Care
- EVEX Industrials
- Exchange
- IMCR Nasdaq
- EVEX Nasdaq
- Market Cap
- IMCR 1.5B
- EVEX 1.3B
- IPO Year
- IMCR 2021
- EVEX N/A
- Fundamental
- Price
- IMCR $32.77
- EVEX $6.67
- Analyst Decision
- IMCR Buy
- EVEX Strong Buy
- Analyst Count
- IMCR 10
- EVEX 3
- Target Price
- IMCR $58.13
- EVEX $6.67
- AVG Volume (30 Days)
- IMCR 445.1K
- EVEX 382.2K
- Earning Date
- IMCR 08-07-2025
- EVEX 08-05-2025
- Dividend Yield
- IMCR N/A
- EVEX N/A
- EPS Growth
- IMCR N/A
- EVEX N/A
- EPS
- IMCR N/A
- EVEX N/A
- Revenue
- IMCR $333,581,000.00
- EVEX N/A
- Revenue This Year
- IMCR $26.82
- EVEX N/A
- Revenue Next Year
- IMCR $8.15
- EVEX N/A
- P/E Ratio
- IMCR N/A
- EVEX N/A
- Revenue Growth
- IMCR 25.75
- EVEX N/A
- 52 Week Low
- IMCR $23.15
- EVEX $2.33
- 52 Week High
- IMCR $41.54
- EVEX $7.47
- Technical
- Relative Strength Index (RSI)
- IMCR 45.73
- EVEX 68.93
- Support Level
- IMCR $30.76
- EVEX $5.36
- Resistance Level
- IMCR $32.55
- EVEX $7.47
- Average True Range (ATR)
- IMCR 1.39
- EVEX 0.39
- MACD
- IMCR -0.41
- EVEX 0.10
- Stochastic Oscillator
- IMCR 19.09
- EVEX 67.08
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About EVEX Eve Holding Inc.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.